These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10232453)

  • 1. Side-effects of high-dose fluticasone propionate in children.
    Todd GR
    Eur Respir J; 1999 Mar; 13(3):707-9. PubMed ID: 10232453
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
    Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
    Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.
    Mohn A; Verini M; Mele R; De Leonardis C; Chiarelli F
    Eur Respir J; 2004 Feb; 23(2):354-5. PubMed ID: 14979518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchial asthma. Fluticasone propionate, a new inhalational corticosteroid defines new reference standards. "Advancing Corticosteroid Therapy" Symposium, Amsterdam, 6 May 1994].
    Fortschr Med Suppl; 1995; 167():1-14. PubMed ID: 7749661
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth and adrenal suppression due to moderate- to high-dose inhaled fluticasone.
    Chatzimichail A; Pietrobelli A; Boner AL
    J Paediatr Child Health; 2002 Dec; 38(6):623. PubMed ID: 12410884
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM; Faulds D; Sorkin EM
    Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate.
    Zimmerman B; Gold M; Wherrett D; Hanna AK
    J Allergy Clin Immunol; 1998 Mar; 101(3):425-6. PubMed ID: 9525464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma].
    Lange P; Vestbo J
    Ugeskr Laeger; 1996 Jan; 158(4):439-44. PubMed ID: 8638310
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth and collagen synthesis disorders in asthmatic children treated with inhaled steroids].
    Martin-du Pan RC; Vonlanthen MC; Dubuis JM
    Rev Med Suisse Romande; 1999 Jun; 119(6):475-9. PubMed ID: 10422472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.
    Drake AJ; Howells RJ; Shield JP; Prendiville A; Ward PS; Crowne EC
    BMJ; 2002 May; 324(7345):1081-2. PubMed ID: 11991916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal suppression with inhaled corticosteroids.
    Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose inhaled steroids in asthmatic children.
    Lenney W
    Lancet; 1996 Sep; 348(9030):819-20. PubMed ID: 8813995
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose inhaled steroids in asthmatic children.
    Cade A; Butler GE; Morrison JF; Chetcuti PJ
    Lancet; 1996 Sep; 348(9030):819. PubMed ID: 8813994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.